Interestingly, serglycin, which is overexpressed in some tumors such as breast cancer, NSCLC or multiple myeloma and secreted by them 150, 151, 152, 153, is modified by C‐4‐S chains 151, 152. Here, SRGN is linked to non-small cell lung carcinoma.